Sage Therapeutics, Cytokinetics and Arcus Biosciences are three small-cap US biotech names with upcoming clinical catalysts.

Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. When it comes to biotech ETFs, they give sector participants exposure to many biotech companies via one ...

The S&P/ASX Small Ordinaries Index (ASX: XSO) finished at 3,505 points, down 6.4 points or 0.18% in the latest session, but ...

CorMedix CRMD and Theravance Biopharma TBPH occupy a similar niche in the market as small-cap biopharmaceutical companies working to turn promising science into sustainable revenues. Both companies, ...

In this article, we will look at the 10 Best Small Cap Biotech Stocks to Buy According to Hedge Funds. On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer ...

However, an elite group of small-cap stocks has presented unique and focused opportunities for investors. Sign up for stock ...

Both Iovance Biotherapeutics IOVA and Rigel Pharmaceuticals RIGL are small-cap companies focused on the successful commercialization of their marketed products. While Iovance is a cancer biotech ...

From broad domestic exposure to global pharma and biotech, these funds cover the healthcare sector's main themes.

ORLANDO, FL / ACCESS Newswire / April 2, 2026 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today announced its upcoming ...